Home
>
National Drug Code (NDC)
>
CYZONE
CYZONE - 13537-435-01 - (Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole)
Drug Information of CYZONE
| Product NDC: | 13537-435 |
| Proprietary Name: | CYZONE |
| Non Proprietary Name: | Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole |
| Active Ingredient(s): | .03; .075; .05; .07; .06; .468 g/g; g/g; g/g; g/g; g/g; g/g & nbsp; Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CYZONE
| Product NDC: | 13537-435 |
| Labeler Name: | Ventura Corporation LTD. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120914 |
Package Information of CYZONE
| Package NDC: | 13537-435-01 |
| Package Description: | 60 g in 1 TUBE (13537-435-01) |
NDC Information of CYZONE
| NDC Code | 13537-435-01 |
| Proprietary Name | CYZONE |
| Package Description | 60 g in 1 TUBE (13537-435-01) |
| Product NDC | 13537-435 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate, Octocrylene, Oxybenzone, Octisalate, Titanium Dioxide, and Ensulizole |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20120914 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation LTD. |
| Substance Name | ENSULIZOLE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE |
| Strength Number | .03; .075; .05; .07; .06; .468 |
| Strength Unit | g/g; g/g; g/g; g/g; g/g; g/g |
| Pharmaceutical Classes |
